Pharmacogenomics and essential hypertension
| ISRCTN | ISRCTN65522010 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN65522010 |
| Secondary identifying numbers | N0016103328 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 11/08/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Martin R Wilkins
Scientific
Scientific
Department of Clinical Pharmacology
Imperial College School of Medicine
Hammersmith Hospital
Du Cane Road
London
W12 0HS
United Kingdom
| Phone | +44 20 8383 2049 |
|---|---|
| m.wilkins@ic.ac.uk |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Other |
| Scientific title | Pharmacogenomics and essential hypertension |
| Study objectives | Can we predict the response to antihypertensive drugs from a patient's genotype? |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Cardiovascular: Hypertension |
| Intervention | Randomised controlled trial |
| Intervention type | Other |
| Primary outcome measure | Response to treatment |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/05/2001 |
| Completion date | 31/01/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | 400 patients |
| Key inclusion criteria | Not provided at time of registration |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/05/2001 |
| Date of final enrolment | 31/01/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of Clinical Pharmacology
London
W12 0HS
United Kingdom
W12 0HS
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.doh.gov.uk |
|---|
Funders
Funder type
Hospital/treatment centre
Hammersmith Hospital NHS Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
11/08/21016: No publications found in PubMed, verifying study status with principal investigator.
